Approval · Notice of Compliance 14283 · 2013
FUROSEMIDE INJECTION: Notice of Compliance 14283
Issued April 12, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14283
- Date
- April 12, 2013
- Company
- Omega Laboratories LimitedMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing site
- Therapeutic class
- Diuretic
- Canadian reference product
- FUROSOMIDE INJECTION USP (Sandoz Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FUROSEMIDE INJECTION | Not yet assigned | — |
Medicinal ingredients
- FUROSEMIDE 10 MG per ML